L

LIFNano Therapeutics

10 employees

LIFNano Therapeutics specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor.

Basic info

Industry

nanotechnology research

Sectors

Biotechnology
Nano medicine
Therapeutics
Multiple Sclerosis
Nanotechnology
Medical
Neurodegenerative diseases

Date founded

2013

Funding rounds raised

Total raised

$1.3M

from 2 investors over 2 rounds

L

LIFNano Therapeutics raised $1.3M on December 1, 2016

Investors: Innovate UK

L

LIFNano Therapeutics raised undisclosed on March 7, 2016

Investors: Pitch@Palace

FAQ